Sosei Group: Notice of Change of Corporate Name to Nxera

Tokyo, Japan and Cambridge, UK, 16 February 2024 – Sosei Group Corporation (“Sosei Heptares” or “the Company”; TSE: 4565), today announces that at a...

Related Keywords

Japan ,Chiyoda Ku ,Tokyo ,Cambridge ,Cambridgeshire ,United Kingdom ,Japanese ,Sosei Heptares ,Akasaka Minato Ku ,Kentaro Tahara ,Shinichiro Nishishita ,Frazer Hall ,Maya Bennison ,Nxera Pharma Kabushiki Kaisha ,Erica Hollingsworth ,Board Of Directors Sosei Co ,Sosei Co ,Sosei Group Kabushiki Kaisha ,Nxera Pharma Japan Co Ltd ,Sosei Group Corporation Heptares ,Heptares Therapeutics Ltd ,Idorsia Pharmaceuticals Korea Co Ltd ,Nxera Pharma Korea Co Ltd ,Medistrava Consulting For International Media ,Idorsia Pharmaceuticals Japan Ltd ,Head Office Of The Company ,Sosei Group Corporation ,Nxera Pharma United Kingdom ,Nxera Pharma Co Ltd ,Head Office ,Board Of Directors The Company ,Ordinary General Meeting ,Merger Agreement ,Corporate Name ,Group Kabushiki Kaisha ,Pharma Kabushiki Kaisha ,Supplementary Provisions ,Corporate Strategy ,International Media ,Japan Exchange Group 4565 T ,Pcr ,Dharma ,Iopharma ,